Hikma Pharmaceuticals PLC
1973.50
23-December-24 11:28:55
15 minutes delayed
Stocks
+21.50
+1.10%
Today's range
1932.00 - 1976.00
ISIN
N/A
Source
Cboe
-
Hikma Pharma Extends Recall Of Acetaminophen Injection
23 Jul 2024 03:11:57 By NASDAQ US Markets
-
Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets
17 Jun 2024 02:45:01 By NASDAQ US Markets
-
Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US
29 Apr 2024 09:07:49 By NASDAQ US Markets
-
Hikma Pharma FY Profit Increases
22 Feb 2024 03:52:27 By NASDAQ US Markets
-
Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US
05 Feb 2024 07:48:52 By NASDAQ US Markets
-
Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa
08 Jan 2024 03:35:52 By NASDAQ US Markets
-
Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15
01 Sep 2023 01:51:58 By NASDAQ Stocks
-
Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics
03 Aug 2023 03:46:32 By NASDAQ US Markets
-
Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation
04 May 2023 20:30:46 By NASDAQ Stocks
-
Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1
12 Apr 2023 02:25:53 By NASDAQ US Markets
-
Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up
23 Feb 2023 04:10:05 By NASDAQ US Markets
-
Hikma accuses Amarin of suppressing generic versions of heart pill
22 Feb 2023 17:13:30 By NASDAQ US Markets
-
Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.
03 Jan 2023 03:15:34 By NASDAQ US Markets
-
Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma
29 Apr 2022 23:58:14 By NASDAQ US Markets
-
U.S. FTC approves Hikma deal for Custopharm with conditions
19 Apr 2022 14:04:52 By NASDAQ US Markets
-
Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down
24 Feb 2022 03:43:25 By NASDAQ US Markets
-
Hikma To Acquire Teligent's Canadian Assets - Quick Facts
17 Jan 2022 03:32:15 By NASDAQ US Markets
-
Hikma Pharma Launches Outsourced Sterile Compounding Business - Quick Facts
10 Jan 2022 02:48:45 By NASDAQ US Markets
- <<
- <
- 1
- >